title: Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution.
abstract: Whole genome sequencing was used to characterize the resistome of intensive care unit (ICU) outbreak-associated carbapenem-resistant K. pneumoniae isolates. Importantly, and of particular concern, the carbapenem-hydrolyzing β-lactamase gene bla(OXA-48) and the extended-spectrum β-lactamase gene bla(CTX-M-14), were identified on a single broad host-range conjugative plasmid. This represents the first report of bla(OXA-48) in Australia and highlights the importance of resistance gene surveillance, as such plasmids can silently spread amongst enterobacterial populations and have the potential to drastically limit treatment options. Furthermore, the in vivo evolution of these isolates was also examined after 18 months of intra-abdominal carriage in a patient that transited through the ICU during the outbreak period. Reflecting the clonality of K. pneumoniae, only 11 single nucleotide polymorphisms (SNPs) were accumulated during this time-period and many of these were associated with genes involved in tolerance/resistance to antibiotics, metals or organic solvents, and transcriptional regulation. Collectively, these SNPs are likely to be associated with changes in virulence (at least to some extent) that have refined the in vivo colonization capacity of the original outbreak isolate.
authors.affiliation: Antibiotic Resistance and Mobile Elements Group, School of Medicine, University of Western Sydney, New South Wales, Australia.
authors.forename: Björn A
authors.initials: BA
authors.lastname: Espedido
authors.forename: Jason A
authors.initials: JA
authors.lastname: Steen
authors.forename: Helen
authors.initials: H
authors.lastname: Ziochos
authors.forename: Sean M
authors.initials: SM
authors.lastname: Grimmond
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Cooper
authors.forename: Iain B
authors.initials: IB
authors.lastname: Gosbell
authors.forename: Sebastiaan J
authors.initials: SJ
authors.lastname: van Hal
authors.forename: Slade O
authors.initials: SO
authors.lastname: Jensen
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001315:Australia / Q000453:epidemiology; D015780:Carbapenems / Q000494:pharmacology*; D003428:Cross Infection / Q000382:microbiology; D004269:DNA, Bacterial / Q000235:genetics; D004196:Disease Outbreaks; D024881:Drug Resistance, Bacterial; D016680:Genome, Bacterial; D006801:Humans; D007362:Intensive Care Units; D007710:Klebsiella Infections / Q000453:epidemiology / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity; D010957:Plasmids / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D017422:Sequence Analysis, DNA; D014158:Transcription, Genetic; D014774:Virulence; D001618:beta-Lactamases / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D004269:DNA, Bacterial; C456080:beta-lactamase CTX-M-14; D001618:beta-Lactamases; C108449:oxacillinase
references.citation: Antimicrob Agents Chemother. 1996 Apr;40(4):879-85
references.pmid: 8849244
references.citation: Int J Antimicrob Agents. 2012 Jun;40 Suppl:S4-10
references.pmid: 22749058
references.citation: J Antimicrob Chemother. 2012 Jul;67(7):1597-606
references.pmid: 22499996
references.citation: J Clin Microbiol. 2007 Feb;45(2):453-60
references.pmid: 17108068
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):1892-7
references.pmid: 19258263
references.citation: Pathology. 2012 Jan;44(1):42-4
references.pmid: 22157689
references.citation: J Antimicrob Chemother. 2006 Mar;57(3):373-83
references.pmid: 16446375
references.citation: J Med Microbiol. 2010 Jun;59(Pt 6):702-707
references.pmid: 20185552
references.citation: Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4550-5
references.pmid: 22393007
references.citation: J Antimicrob Chemother. 2011 Dec;66(12):2763-6
references.pmid: 22191089
references.citation: PLoS One. 2012;7(4):e34752
references.pmid: 22511964
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D225-9
references.pmid: 21109532
references.citation: Microbiology (Reading). 2008 Dec;154(Pt 12):3609-3623
references.pmid: 19047729
references.citation: Antimicrob Agents Chemother. 2010 Mar;54(3):1369-73
references.pmid: 20086157
references.citation: Antimicrob Agents Chemother. 2004 Jan;48(1):1-14
references.pmid: 14693512
references.citation: Antimicrob Agents Chemother. 2008 May;52(5):1843-5
references.pmid: 18347105
references.citation: Antimicrob Agents Chemother. 2008 Aug;52(8):2984-7
references.pmid: 18490506
references.citation: Antimicrob Agents Chemother. 2008 Mar;52(3):1028-33
references.pmid: 18086836
references.citation: J Biol Chem. 2004 Sep 10;279(37):38618-25
references.pmid: 15208313
references.citation: Lancet Infect Dis. 2011 May;11(5):381-93
references.pmid: 21530894
references.citation: J Clin Microbiol. 2005 Aug;43(8):4178-82
references.pmid: 16081970
references.citation: Infect Control Hosp Epidemiol. 2008 Dec;29(12):1099-106
references.pmid: 18973455
references.citation: Int J Antimicrob Agents. 2012 Aug;40(2):191-2
references.pmid: 22743013
references.citation: J Mol Biol. 1988 Jul 5;202(1):45-58
references.pmid: 3050121
references.citation: Antimicrob Agents Chemother. 1995 Apr;39(4):887-93
references.pmid: 7785990
references.citation: Infect Immun. 1997 Sep;65(9):3725-30
references.pmid: 9284144
references.citation: Antimicrob Agents Chemother. 2004 Jan;48(1):15-22
references.pmid: 14693513
references.citation: Antimicrob Agents Chemother. 2011 Sep;55(9):4398-401
references.pmid: 21746954
references.citation: J Antimicrob Chemother. 2011 Jul;66(7):1644-6
references.pmid: 21565807
references.citation: Clin Infect Dis. 2011 Feb 15;52(4):481-4
references.pmid: 21258100
references.citation: Antimicrob Agents Chemother. 1997 Oct;41(10):2188-95
references.pmid: 9333046
references.citation: Antimicrob Agents Chemother. 2012 Jan;56(1):559-62
references.pmid: 22083465
references.citation: Structure. 1999 Apr 15;7(4):425-34
references.pmid: 10196126
references.citation: J Antimicrob Chemother. 2013 Feb;68(2):476-7
references.pmid: 23027715
references.citation: Antimicrob Agents Chemother. 2010 Jul;54(7):3043-6
references.pmid: 20421398
references.citation: Int J Antimicrob Agents. 2010 Nov;36(5):408-14
references.pmid: 20728316
references.citation: Arch Microbiol. 2003 Nov;180(5):339-46
references.pmid: 13680098
references.citation: Int J Antimicrob Agents. 2013 Mar;41(3):294-6
references.pmid: 23313398
references.citation: J Biol Chem. 2011 Jun 24;286(25):22178-85
references.pmid: 21550983
references.citation: J Biol Chem. 2011 Sep 16;286(37):32026-35
references.pmid: 21768111
references.citation: Antimicrob Agents Chemother. 2011 Dec;55(12):5933-5
references.pmid: 21911569